• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

O-GlcNAcylation 决定了关键的 O-GalNAc 糖基转移酶 C1GalT1 在膀胱癌中的功能。

O-GlcNAcylation determines the function of the key O-GalNAc glycosyltransferase C1GalT1 in bladder cancer.

机构信息

Institute for Cancer Research, School of Basic Medical Science, Xi'an Jiaotong University, Xi'an 710061, China.

Department of Urology, the Third Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710068, China.

出版信息

Acta Biochim Biophys Sin (Shanghai). 2024 Aug 8;56(8):1108-1117. doi: 10.3724/abbs.2024129.

DOI:10.3724/abbs.2024129
PMID:39126245
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11399441/
Abstract

Protein glycosylation is a type of protein post-translational modification. One specific example is the modification of proteins with O-linked β-N-acetylglucosamine (O-GlcNAc) and O-linked α-N-acetylgalactosamine (O-GalNAc). Enhanced levels of both O-GalNAc and O-GlcNAc in bladder cancer (BlCa) have been reported previously. However, the interplay between O-GalNAc and O-GlcNAc has yet to be explored. Herein, we find that the expression level of core1 β-1,3-galactosyltransferase (C1GalT1), which is responsible for extending and maturing mucin-type O-glycans, is increased in BlCa. This increase is accompanied by O-GlcNAc modification of C1GalT1. This modification stabilizes C1GalT1 expression and strengthens its interaction with its chaperone Cosmc. Mutation at Thr229 or Thr233 attenuates C1GalT1 stability and facilitates its degradation via the proteasome pathway. Furthermore, a decrease in C1GalT1 inhibits the pro-tumorigenic effect on bladder cancer cells by suppressing glycolysis.

摘要

蛋白质糖基化是一种蛋白质翻译后修饰。一个具体的例子是用 O-连接的 β-N-乙酰葡萄糖胺 (O-GlcNAc) 和 O-连接的 α-N-乙酰半乳糖胺 (O-GalNAc) 修饰蛋白质。先前有报道称膀胱癌 (BlCa) 中 O-GalNAc 和 O-GlcNAc 的水平都增强了。然而,O-GalNAc 和 O-GlcNAc 之间的相互作用尚未被探索。在这里,我们发现负责延伸和成熟粘蛋白型 O-聚糖的核心 1 β-1,3-半乳糖基转移酶 (C1GalT1) 的表达水平在 BlCa 中增加。这种增加伴随着 C1GalT1 的 O-GlcNAc 修饰。这种修饰稳定了 C1GalT1 的表达,并增强了它与伴侣 Cosmc 的相互作用。在 Thr229 或 Thr233 处发生突变会减弱 C1GalT1 的稳定性,并通过蛋白酶体途径促进其降解。此外,C1GalT1 的减少通过抑制糖酵解抑制了对膀胱癌细胞的促肿瘤作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0049/11399441/72ee9add5b5c/abbs-2023-630-t5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0049/11399441/3f6dd127f9ba/abbs-2023-630-t1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0049/11399441/0771d8629d8f/abbs-2023-630-t2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0049/11399441/36a522f755a9/abbs-2023-630-t3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0049/11399441/d87472e97047/abbs-2023-630-t4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0049/11399441/72ee9add5b5c/abbs-2023-630-t5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0049/11399441/3f6dd127f9ba/abbs-2023-630-t1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0049/11399441/0771d8629d8f/abbs-2023-630-t2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0049/11399441/36a522f755a9/abbs-2023-630-t3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0049/11399441/d87472e97047/abbs-2023-630-t4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0049/11399441/72ee9add5b5c/abbs-2023-630-t5.jpg

相似文献

1
O-GlcNAcylation determines the function of the key O-GalNAc glycosyltransferase C1GalT1 in bladder cancer.O-GlcNAcylation 决定了关键的 O-GalNAc 糖基转移酶 C1GalT1 在膀胱癌中的功能。
Acta Biochim Biophys Sin (Shanghai). 2024 Aug 8;56(8):1108-1117. doi: 10.3724/abbs.2024129.
2
SLC35A2 deficiency reduces protein levels of core 1 β-1,3-galactosyltransferase 1 (C1GalT1) and its chaperone Cosmc and affects their subcellular localization.SLC35A2 缺乏会降低核心 1 β-1,3-半乳糖基转移酶 1(C1GalT1)及其伴侣蛋白 Cosmc 的蛋白水平,并影响它们的亚细胞定位。
Biochim Biophys Acta Mol Cell Res. 2023 Jun;1870(5):119462. doi: 10.1016/j.bbamcr.2023.119462. Epub 2023 Mar 17.
3
Dysregulation and prometastatic function of glycosyltransferase C1GALT1 modulated by cHP1BP3/ miR-1-3p axis in bladder cancer.膀胱癌中 C1GALT1 通过 cHP1BP3/miR-1-3p 轴的失调和促转移功能。
J Exp Clin Cancer Res. 2022 Jul 21;41(1):228. doi: 10.1186/s13046-022-02438-7.
4
C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer.C1GALT1 与不良预后相关,并通过激活胃癌中的 Ephrin A1 介导的细胞迁移 EPHA2 促进可溶性 Ephrin A1 的迁移。
Oncogene. 2020 Mar;39(13):2724-2740. doi: 10.1038/s41388-020-1178-7. Epub 2020 Jan 31.
5
C1GALT1 in health and disease.健康与疾病中的C1GALT1
Oncol Lett. 2021 Aug;22(2):589. doi: 10.3892/ol.2021.12850. Epub 2021 Jun 6.
6
C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2.C1GALT1过表达通过修饰FGFR2的O-糖基化促进结肠癌细胞的侵袭行为。
Oncotarget. 2014 Apr 30;5(8):2096-106. doi: 10.18632/oncotarget.1815.
7
Substrate O-glycosylation actively regulates extracellular proteolysis.底物 O-糖基化可主动调节细胞外蛋白水解。
Protein Sci. 2024 Aug;33(8):e5128. doi: 10.1002/pro.5128.
8
Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway.C1GALT1的上调通过MUC1-C信号通路促进乳腺癌细胞生长。
Oncotarget. 2015 Mar 20;6(8):6123-35. doi: 10.18632/oncotarget.3045.
9
TGF-β1 mimics the effect of IL-4 on the glycosylation of IgA1 by downregulating core 1 β1, 3-galactosyltransferase and Cosmc.转化生长因子-β1通过下调核心1 β1,3-半乳糖基转移酶和Cosmc来模拟白细胞介素-4对免疫球蛋白A1糖基化的作用。
Mol Med Rep. 2017 Feb;15(2):969-974. doi: 10.3892/mmr.2016.6084. Epub 2016 Dec 29.
10
C1GALT1-mediated O-glycan T antigen increase enhances the migration and invasion ability of gastric cancer cells.C1GALT1 介导的 O-聚糖 T 抗原增加增强了胃癌细胞的迁移和侵袭能力。
Biochem Biophys Res Commun. 2024 Nov 19;734:150641. doi: 10.1016/j.bbrc.2024.150641. Epub 2024 Sep 4.

引用本文的文献

1
Galectin-3: Integrator of Signaling via Hexosamine Flux.半乳糖凝集素-3:通过己糖胺通量的信号整合因子。
Biomolecules. 2025 Jul 16;15(7):1028. doi: 10.3390/biom15071028.
2
Exploring glyco-signatures and their clinical implications: a special issue focused on glycosylation studies.探索糖基化特征及其临床意义:聚焦糖基化研究的特刊
Acta Biochim Biophys Sin (Shanghai). 2024 Aug 15;56(8):1097-1098. doi: 10.3724/abbs.2024143.

本文引用的文献

1
What are the diagnostic capabilities of glycans for breast cancer?聚糖对乳腺癌的诊断能力有哪些?
Expert Rev Mol Diagn. 2023 Jan;23(1):1-7. doi: 10.1080/14737159.2023.2173577. Epub 2023 Feb 3.
2
Dysregulation and prometastatic function of glycosyltransferase C1GALT1 modulated by cHP1BP3/ miR-1-3p axis in bladder cancer.膀胱癌中 C1GALT1 通过 cHP1BP3/miR-1-3p 轴的失调和促转移功能。
J Exp Clin Cancer Res. 2022 Jul 21;41(1):228. doi: 10.1186/s13046-022-02438-7.
3
Demystifying the O-GlcNAc Code: A Systems View.揭开 O-GlcNAc 密码:系统视角
Chem Rev. 2022 Oct 26;122(20):15822-15864. doi: 10.1021/acs.chemrev.1c01006. Epub 2022 Mar 18.
4
Simultaneously Identifying and Distinguishing Glycoproteins with O-GlcNAc and O-GalNAc (the Tn Antigen) in Human Cancer Cells.同时鉴定和区分人类癌细胞中的 O-GlcNAc 和 O-GalNAc(Tn 抗原)糖蛋白。
Anal Chem. 2022 Feb 22;94(7):3343-3351. doi: 10.1021/acs.analchem.1c05438. Epub 2022 Feb 8.
5
Mucin-Type O-GalNAc Glycosylation in Health and Disease.黏蛋白型 O-糖基化在健康和疾病中的作用。
Adv Exp Med Biol. 2021;1325:25-60. doi: 10.1007/978-3-030-70115-4_2.
6
Melatonin reduces proliferation and promotes apoptosis of bladder cancer cells by suppressing O-GlcNAcylation of cyclin-dependent-like kinase 5.褪黑素通过抑制细胞周期蛋白依赖性样激酶5的O-连接N-乙酰葡糖胺化来减少膀胱癌细胞的增殖并促进其凋亡。
J Pineal Res. 2021 Oct;71(3):e12765. doi: 10.1111/jpi.12765. Epub 2021 Sep 18.
7
Advances in chemical probing of protein -GlcNAc glycosylation: structural role and molecular mechanisms.蛋白质-GlcNAc 糖基化的化学探测进展:结构作用和分子机制。
Chem Soc Rev. 2021 Sep 20;50(18):10451-10485. doi: 10.1039/d0cs01275k.
8
Analytical and Biochemical Perspectives of Protein O-GlcNAcylation.蛋白质 O-糖基化的分析和生化研究
Chem Rev. 2021 Feb 10;121(3):1513-1581. doi: 10.1021/acs.chemrev.0c00884. Epub 2021 Jan 8.
9
Bisecting GlcNAc modification diminishes the pro-metastatic functions of small extracellular vesicles from breast cancer cells.对半乳糖胺修饰的打断会降低乳腺癌细胞来源的小细胞外囊泡的促转移功能。
J Extracell Vesicles. 2020 Oct;10(1):e12005. doi: 10.1002/jev2.12005. Epub 2020 Oct 30.
10
Bladder Cancer: A Review.膀胱癌:综述。
JAMA. 2020 Nov 17;324(19):1980-1991. doi: 10.1001/jama.2020.17598.